Both theshortstrangle and theshort straddle strategies employed on Pfizer today indicate investors expect volatility in the price of the underlying shares to decline going forward.
The July and August contracts saw heaviest volume at the 42.5 call and 37.5 strikes, which may well have been the implementation of shortstrangle trades, in which investors sell equal amounts of calls and puts.